Power Moves and Pivotal Research in the Health Sector: New Collaborations, Challenges, and Innovations
Published on: April 11, 2026, 6:32 p.m. | Source: Devdiscourse
The health sector sees significant developments with C4 Therapeutics and Roche forming a billion-dollar cancer drug deal, AG1 considering sale options, Granules improving practices after FDA warnings, and studies linking genetics to GLP-1 drug efficacy. Meanwhile, shortages of estrogen patches and challenges in the vaccine safety debate demonstrate ongoing sector challenges.
